News

Graduate research students from The Ritchie Centre took the lion’s share of awards at the recent Perinatal Society of Australia and New Zealand (PSANZ) annual scientific meeting.…  Read more

A woman’s pre-pregnancy diet could have a greater impact on fertility and pregnancy than previously thought, according to new research by Hudson Institute of Medical Research scientists. The study found that certain proteins, which become ‘toxic’ after exposure to sugar, trigger inflammation in the womb in infertile women with obesity. This may reduce the likelihood…  Read more

Precision medicine is providing new hope for patients with ovarian cancer, the most common cause of death from gynaecological cancers. Only 3 out of every 10 women diagnosed with advanced stage ovarian cancer will survive after five years. These statistics haven’t improved in 30 years, but precision medicine approaches are opening up new possibilities. While…  Read more

Hudson Institute researchers are closer to understanding the fundamental processes that make embryos develop as male, helping the 1 in 5000 babies that are born intersex.…  Read more

Why do seasonal strains of influenza make many people sick yet cause relatively few deaths, while 40 per cent of people affected by strains of avian influenza, or ‘bird flu’, succumb to their infection? A discovery by Associate Professor Ashley Mansell could form a strategy to protect the world’s population from a potential global outbreak…  Read more

A study led by Professor Vincent Harley and Dr Daniel Bird examining the genetic causes of intersex, where a person is born with characteristics that are not clearly male or female…  Read more

A world-first study has shown ‘length does matter’ when using small molecules called microRNAs as potential biomarkers to detect and predict cancer and inflammatory diseases. The study, published in the journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College…  Read more

PhD student, Aidan Kashyap has been selected as a FameLab semi-finalist for his research that is offering hope for babies who struggle to breathe at birth due to underdeveloped lungs. Aidan will compete against 11 other STEM early career researchers in the FameLab Victorian semi-finals at the Melbourne Museum on Wednesday, 28 March 2018. FameLab,…  Read more

Hudson Institute has entered into a Research and Development Alliance Agreement with RMW Cho Group Limited to provide key scientific assessment of the cancer treatment technology, Photosoft. The collaboration will initially focus on the treatment of ovarian cancer, with a view to expanding research and development projects into other forms of cancer. Hudson Institute will…  Read more

The inaugural Dr Sue Fowler Scholarship in Ovarian Cancer has been awarded to PhD student, Mrs Nazanin Karimnia to support her research into new ovarian cancer therapies. The scholarship was established in honour of the late Dr Sue Fowler, to support a Hudson Institute PhD student undertaking research into ovarian cancer. There is an urgent…  Read more